Synthetic Studies on Antineoplastic Marine Prostanoids.

抗肿瘤海洋前列腺素的合成研究。

基本信息

  • 批准号:
    60571004
  • 负责人:
  • 金额:
    $ 1.09万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1985
  • 资助国家:
    日本
  • 起止时间:
    1985 至 1986
  • 项目状态:
    已结题

项目摘要

The structures of chlorinated prostanoids punaglandins (PUGs) isolated from Hawaiian octocoral Telesto riisei have been reported by Scheuer et al. Formula 2 and 1 were postulated for PUG 3 and 4, respectively, which have potent antineoplastic activity. In this research, the synthesis of PUG 3 and 4 has been studied.Firstly, compound 1 was synthesized by linking of the chiral cyclopentenone (-)-3 to the chiral <alpha> -side chain 4 derived from 2-deoxy-D-ribose. However, the synthetic 1 (5S,6S,12S) was not identical with PUG 4. Therefore, all possible diastereomers: 6 (5S,6R,12S); 7 (5S,6S,12R); 9 (5S,6R,12R), were synthesized by analogous synthetic technique. As the result, compound 7 was found to be identical with natural authentic specimen of PUG 4. Similary, synthetic study on PUG 3 revealed its collect structure as 8. Here the total synthesis of both of PUG 3 and 4 was accomplished and it made the structural revision.
Scheuer等人报道了从夏威夷海珊瑚Telesto riisei中分离的氯化前列腺素类punaglandins(PUG)的结构。PUG 3和4分别假定为式2和式1,其具有强的抗肿瘤活性。本研究对PUG 3和PUG 4的合成进行了研究,首先通过手性环戊烯酮(-)-3与<alpha>2-脱氧-D-核糖的手性侧链4连接得到化合物1。然而,合成的1(5S,6S,12 S)与PUG 4不相同。因此,所有可能的非对映异构体:6(5S,6 R,12 S); 7(5S,6S,12 R); 9(5S,6 R,12 R)通过类似的合成技术合成。结果,发现化合物7与PUG 4的天然真实样品相同。对PUG 3的合成研究表明,PUG 3的聚集态结构为8。完成了PUG 3和PUG 4的全合成,并对其结构进行了修正。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hiroto Nagaoka: "Synthesis of Punaglandin 3 and 4. Revision of the Structures" Journal of the American Chemical Society. 108. 5019-5021 (1986)
Hiroto Nagaoka:“Punaglandin 3 和 4 的合成。结构的修订”美国化学会杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hiroto Nagaoka: Journal of the American Chemical Society. 108. 5019-5021 (1986)
长冈博人:美国化学会杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMADA Yasuji其他文献

Superconducting Joint for REBCO-Coated Conductors without Oxidization Annealing via Low-temperature Synthesis Reaction Using Potassium Hydroxide
利用氢氧化钾低温合成反应无需氧化退火的 REBCO 涂层导体超导接头

YAMADA Yasuji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMADA Yasuji', 18)}}的其他基金

Synthetic Studies on Protein Phosphatase Inhibitor Dysidiolide
蛋白磷酸酶抑制剂地西二内酯的合成研究
  • 批准号:
    09672165
  • 财政年份:
    1997
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The Thromboxane-Prostanoid Receptor in Radiation-Induced Pulmonary Fibrosis
辐射诱发肺纤维化中的血栓素-前列腺素受体
  • 批准号:
    10734570
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
Targeted prostanoid inhibition as an anti-inflammatory therapy for diabetic retinopathy
靶向前列腺素抑制作为糖尿病视网膜病变的抗炎治疗
  • 批准号:
    10751497
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
DNA event recording of the pericellular microenvironment, to understand the causes and mechanisms of beta-cell loss in pancreatic islet tissue
细胞周微环境的 DNA 事件记录,以了解胰岛组织中 β 细胞损失的原因和机制
  • 批准号:
    472586
  • 财政年份:
    2022
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Operating Grants
Role of prostanoid-related mediators in restraint stress-induced sympathetic activation
前列腺素相关介质在束缚应激诱导的交感神经激活中的作用
  • 批准号:
    20K22695
  • 财政年份:
    2020
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Explore the irreversible check point from normal to malignant transformation of the cells by changing in the balance of the expression levels of the EP prostanoid receptor subtypes.
通过改变EP前列腺素受体亚型表达水平的平衡,探索细胞从正常向恶性转化的不可逆检查点。
  • 批准号:
    20K07084
  • 财政年份:
    2020
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of prostanoid receptor subtype conversion and colorectal cancer development/malignancy mechanism
阐明前列腺素受体亚型转换和结直肠癌发生/恶性机制
  • 批准号:
    19K16374
  • 财政年份:
    2019
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of dysfunctional labour associated with steroid and prostanoid signalling
与类固醇和前列腺素信号传导相关的功能障碍性分娩的机制
  • 批准号:
    408178
  • 财政年份:
    2018
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Studentship Programs
Prostaglandin E2, Immunity and hypertension
前列腺素 E2、免疫与高血压
  • 批准号:
    10077572
  • 财政年份:
    2018
  • 资助金额:
    $ 1.09万
  • 项目类别:
Mechanism of HTLV1-infected cell tumorigenesis in UV-exposed skin with high prostanoid environment
高前列腺素环境下紫外线暴露皮肤中HTLV1感染细胞肿瘤发生机制
  • 批准号:
    18K16066
  • 财政年份:
    2018
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Expression of prostanoid receptors and induction of positive remodeling in vein grafts
静脉移植物中前列腺素受体的表达和正向重塑的诱导
  • 批准号:
    17K10766
  • 财政年份:
    2017
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了